Synopsis
Synopsis
0
EU WC
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Garamycin Solution
2. Gentimicin Sulfate Solution
3. Gentamicin Sulfate, 500x Solution
4. Akos015895526
5. G0383
| Molecular Weight | 575.7 g/mol |
|---|---|
| Molecular Formula | C21H45N5O11S |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 7 |
| Exact Mass | 575.28362844 g/mol |
| Monoisotopic Mass | 575.28362844 g/mol |
| Topological Polar Surface Area | 283 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 717 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 13 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Genoptic |
| PubMed Health | Gentamicin |
| Drug Classes | Antibacterial, Antibiotic |
| Active Ingredient | Gentamicin sulfate |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | eq 0.3% base |
| Market Status | Prescription |
| Company | Allergan |
| 2 of 2 | |
|---|---|
| Drug Name | Genoptic |
| PubMed Health | Gentamicin |
| Drug Classes | Antibacterial, Antibiotic |
| Active Ingredient | Gentamicin sulfate |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | eq 0.3% base |
| Market Status | Prescription |
| Company | Allergan |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SUSPENSION/DROPS;OPHTHALMIC - EQ 0.3...DOSAGE - SUSPENSION/DROPS;OPHTHALMIC - EQ 0.3% BASE;1%
USFDA APPLICATION NUMBER - 50586
DOSAGE - OINTMENT;OPHTHALMIC - EQ 0.3% BASE;0...DOSAGE - OINTMENT;OPHTHALMIC - EQ 0.3% BASE;0.6%
USFDA APPLICATION NUMBER - 50612
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Curia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Coating Systems & Additives
Film Formers & Plasticizers
Parenteral
Topical
Fillers, Diluents & Binders
Solubilizers
Controlled & Modified Release
Taste Masking
Lubricants & Glidants
Thickeners and Stabilizers
Direct Compression
Chewable & Orodispersible Aids
Emulsifying Agents
Surfactant & Foaming Agents
Co-Processed Excipients
Disintegrants & Superdisintegrants
API Stability Enhancers
Granulation
Soft Gelatin
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
ABOUT THIS PAGE
A Gentamicin Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gentamicin Sulfate, including repackagers and relabelers. The FDA regulates Gentamicin Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gentamicin Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gentamicin Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gentamicin Sulfate supplier is an individual or a company that provides Gentamicin Sulfate active pharmaceutical ingredient (API) or Gentamicin Sulfate finished formulations upon request. The Gentamicin Sulfate suppliers may include Gentamicin Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Gentamicin Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gentamicin Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Gentamicin Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Gentamicin Sulfate DMFs exist exist since differing nations have different regulations, such as Gentamicin Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Gentamicin Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Gentamicin Sulfate USDMF includes data on Gentamicin Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gentamicin Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Gentamicin Sulfate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Gentamicin Sulfate Drug Master File in Japan (Gentamicin Sulfate JDMF) empowers Gentamicin Sulfate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Gentamicin Sulfate JDMF during the approval evaluation for pharmaceutical products. At the time of Gentamicin Sulfate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Gentamicin Sulfate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Gentamicin Sulfate Drug Master File in Korea (Gentamicin Sulfate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Gentamicin Sulfate. The MFDS reviews the Gentamicin Sulfate KDMF as part of the drug registration process and uses the information provided in the Gentamicin Sulfate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Gentamicin Sulfate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Gentamicin Sulfate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Gentamicin Sulfate suppliers with KDMF on PharmaCompass.
A Gentamicin Sulfate CEP of the European Pharmacopoeia monograph is often referred to as a Gentamicin Sulfate Certificate of Suitability (COS). The purpose of a Gentamicin Sulfate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Gentamicin Sulfate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Gentamicin Sulfate to their clients by showing that a Gentamicin Sulfate CEP has been issued for it. The manufacturer submits a Gentamicin Sulfate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Gentamicin Sulfate CEP holder for the record. Additionally, the data presented in the Gentamicin Sulfate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Gentamicin Sulfate DMF.
A Gentamicin Sulfate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Gentamicin Sulfate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Gentamicin Sulfate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gentamicin Sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Gentamicin Sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Gentamicin Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Gentamicin Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gentamicin Sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Gentamicin Sulfate suppliers with NDC on PharmaCompass.
Gentamicin Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gentamicin Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gentamicin Sulfate GMP manufacturer or Gentamicin Sulfate GMP API supplier for your needs.
A Gentamicin Sulfate CoA (Certificate of Analysis) is a formal document that attests to Gentamicin Sulfate's compliance with Gentamicin Sulfate specifications and serves as a tool for batch-level quality control.
Gentamicin Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Gentamicin Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gentamicin Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Gentamicin Sulfate EP), Gentamicin Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gentamicin Sulfate USP).
LOOKING FOR A SUPPLIER?
